jama tirzepatide Ophthalmic Complications Observed After Use of GLP-1 Agonists Tirzepatide vs. Semaglutide for Weight

MAFLD: how is it different from NAFLD

Are there supplements similar to Acetyl-L-Carnitine

According to FDA prescribing information, these effects vary by product and dose: For Ozempic (diabetes treatment): Nausea (15-20% of patients) Diarrhea (8-9% of patients) Vomiting (5-9% of patients) Constipation (3-7% of patients) Abdominal pain (5-6% of patients) For Wegovy (weight management), gastrointestinal effects are more common at the higher therapeutic dose: Nausea (up to 44% of patients) Diarrhea (up to 30% of patients) Vomiting (up to 24% of patients) Constipation (up to 24% of patients) Abdominal pain (up to 20% of patients) These effects are generally mild to moderate and tend to diminish with continued use

Therefore, individuals on both thyroid medication and GLP-1s need their thyroid hormone levels monitored more frequently, as their dosage may need to be adjusted downward over time to avoid overtreatment